HENRY SCHEIN, INC. Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest
HENRY SCHEIN, INC. (HSIC) reported Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest of $21.00 million for the 12-month period ending 2025-12-27, per its 10-K filed 2026-02-24.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity · last filed 2026-02-24
- HENRY SCHEIN, INC. income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for the quarter ending 2021-12-25 was $4.62M, a 9.04% decline year-over-year.
- HENRY SCHEIN, INC. income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for the quarter ending 2021-09-25 was $7.19M, a 28.74% decline year-over-year.
- HENRY SCHEIN, INC. income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for the quarter ending 2021-06-26 was $8.26M.
- HENRY SCHEIN, INC. income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for the quarter ending 2021-03-27 was $8.93M, a 170.31% increase year-over-year.
- HENRY SCHEIN, INC. income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for fiscal 2025 was $21.00M, a 162.50% increase from fiscal 2024.
- HENRY SCHEIN, INC. income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for fiscal 2024 was $8.00M, a 60.00% decline from fiscal 2023.
- HENRY SCHEIN, INC. income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for fiscal 2023 was $20.00M, a 28.57% decline from fiscal 2022.
- HENRY SCHEIN, INC. income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for fiscal 2022 was $28.00M, a 3.45% decline from fiscal 2021.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest 12 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-27 | $21.00M 10-K · filed 2026-02-24 | ||||
| 2024-12-28 | $8.00M 10-K · filed 2026-02-24 | ||||
| 2023-12-30 | $20.00M 10-K · filed 2026-02-24 | ||||
| 2022-12-31 | $28.00M 10-K · filed 2025-02-25 | ||||
| 2021-12-25 | $4.62M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $11.81M derived: sum of 2 quarters · filed 2024-02-28 | $20.07M derived: sum of 3 quarters · filed 2024-02-28 | $29.00M 10-K · filed 2024-02-28 | $29.29M 10-K · filed 2022-02-15 |
| 2021-09-25 | $7.19M 10-Q · filed 2021-11-02 | $15.45M derived: sum of 2 quarters · filed 2021-11-02 | $24.38M 10-Q · filed 2021-11-02 | $29.46M derived: sum of 4 quarters · filed 2023-02-21 | |
| 2021-06-26 | $8.26M 10-Q · filed 2021-08-03 | $17.19M 10-Q · filed 2021-08-03 | $22.27M derived: sum of 3 quarters · filed 2023-02-21 | $32.36M derived: sum of 4 quarters · filed 2023-02-21 | |
| 2021-03-27 | $8.93M 10-Q · filed 2021-05-04 | $14.01M derived: sum of 2 quarters · filed 2023-02-21 | $24.10M derived: sum of 3 quarters · filed 2023-02-21 | $21.63M derived: sum of 4 quarters · filed 2023-02-21 | |
| 2020-12-26 | $5.08M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $15.17M derived: sum of 2 quarters · filed 2023-02-21 | $12.70M derived: sum of 3 quarters · filed 2023-02-21 | $16.00M 10-K · filed 2023-02-21 | $15.63M 10-K · filed 2021-02-17 |
| 2020-09-26 | $10.09M 10-Q · filed 2021-11-02 | $7.62M derived: sum of 2 quarters · filed 2021-11-02 | $10.92M 10-Q · filed 2021-11-02 | $17.50M derived: sum of 4 quarters · filed 2022-02-15 | |
| 2020-06-27 | -$2.47M 10-Q · filed 2021-08-03 | $834.00K 10-Q · filed 2021-08-03 | $7.42M derived: sum of 3 quarters · filed 2022-02-15 | $15.71M derived: sum of 4 quarters · filed 2022-02-15 | |
| 2020-03-28 | $3.30M 10-Q · filed 2021-05-04 | $9.89M derived: sum of 2 quarters · filed 2022-02-15 | $18.18M derived: sum of 3 quarters · filed 2022-02-15 | $22.85M derived: sum of 4 quarters · filed 2022-02-15 | |
| 2019-12-28 | $6.58M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $14.88M derived: sum of 2 quarters · filed 2022-02-15 | $19.54M derived: sum of 3 quarters · filed 2022-02-15 | $24.77M 10-K · filed 2022-02-15 | |
| 2019-09-28 | $8.30M 10-Q · filed 2020-11-02 | $12.96M derived: sum of 2 quarters · filed 2020-11-02 | $18.19M 10-Q · filed 2020-11-02 | $25.30M derived: sum of 4 quarters · filed 2021-02-17 | |
| 2019-06-29 | $4.66M 10-Q · filed 2020-08-04 | $9.89M 10-Q · filed 2020-08-04 | $17.00M derived: sum of 3 quarters · filed 2021-02-17 | $22.48M derived: sum of 4 quarters · filed 2021-02-17 | |
| 2019-03-30 | $5.23M 10-Q · filed 2020-05-05 | $12.34M derived: sum of 2 quarters · filed 2021-02-17 | $17.81M derived: sum of 3 quarters · filed 2021-02-17 | $21.77M derived: sum of 4 quarters · filed 2021-02-17 | |
| 2018-12-29 | $7.11M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $12.59M derived: sum of 2 quarters · filed 2021-02-17 | $16.54M derived: sum of 3 quarters · filed 2021-02-17 | $19.72M 10-K · filed 2021-02-17 | |
| 2018-09-29 | $5.48M 10-Q · filed 2019-11-05 | $9.43M derived: sum of 2 quarters · filed 2019-11-05 | $12.62M 10-Q · filed 2019-11-05 | ||
| 2018-06-30 | $3.96M 10-Q · filed 2019-08-06 | $7.14M 10-Q · filed 2019-08-06 | |||
| 2018-03-31 | $3.18M 10-Q · filed 2019-05-07 | ||||
| 2017-12-30 | $25.30M 10-K · filed 2020-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACCENDRA HEALTH INC/VA/ (ACH) | United States | $0.057B | -0.87 |